0001209191-19-033190.txt : 20190529
0001209191-19-033190.hdr.sgml : 20190529
20190529162513
ACCESSION NUMBER: 0001209191-19-033190
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190528
FILED AS OF DATE: 20190529
DATE AS OF CHANGE: 20190529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duvall Martin J
CENTRAL INDEX KEY: 0001313390
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 19862317
MAIL ADDRESS:
STREET 1: MGI PHARMA, INC.
STREET 2: 5775 WEST OLD SHAKOPEE ROAD, SUITE 100
CITY: BLOOMINGTON
STATE: MN
ZIP: 55437
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tocagen Inc
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 412-8400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-28
0
0001419041
Tocagen Inc
TOCA
0001313390
Duvall Martin J
C/O TOCAGEN INC.
4242 CAMPUS POINT COURT, SUITE 500
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
Common Stock
2019-05-28
4
P
0
5000
4.3357
A
13605
D
Includes 1,566 shares of Common Stock that were acquired by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan and 968 shares of Common Stock that were acquired by the Reporting Person on December 10, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
/s/ Mark Foletta, Attorney-in-Fact
2019-05-29